Celltrion Pharm, Inc.
Research Celltrion Pharm, Inc. (068760.KQ) on Bullrun: market cap KRW 1.72T, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker068760.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 1.72T
- Dividend yield0.5%
- Financial periodQ2 2026
- RevenueKRW 153.29B
- Net incomeKRW 13.72B
- Free cash flowKRW 2.08B
- Gross margin33.0%
Valuation Snapshot
latest market cap is KRW 1.72T; dividend yield is 0.5%.
Peer valuation comparison
Latest dividend yield is 0.51% versus a Healthcare sector median of 2.4% (78.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 1.72T | n/a | 0.5% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 0.5%.
About Celltrion Pharm, Inc.
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Celltrion Pharm, Inc.'s market cap?
Celltrion Pharm, Inc.'s market capitalization is KRW 1.72T.
Does Celltrion Pharm, Inc. pay a dividend?
Celltrion Pharm, Inc. has a dividend yield of 0.5%.
What does Celltrion Pharm, Inc. do?
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.